27/05/2003
ReGen Therapeutics Plc (the ‘Company’) announces that on 27 May 2003 it received notification from Mr P Garrod that he is beneficially interested in 12,800,000 ordinary shares of the Company representing 7.95% of the current issued share capital of the Company.
For further information, please contact:
Andrew Marshall
Tel. 020 7489 2033
Marshall Robinson Roe